Citigroup Inc Zentalis Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 43,686 shares of ZNTL stock, worth $131,058. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,686

Previous 43,926 0.55%

Holding current value

$131,058

Previous $179,000 10.61%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$2.9 - $4.57 $696 - $1,096	-240 Reduced 0.55%	43,686 $160,000
Q2 2024 Aug 12, 2024	SELL	$4.09 - $16.13 $871,828 - $3.44 Million	-213,161 Reduced 82.91%	43,926 $179,000
Q1 2024 May 10, 2024	BUY	$10.83 - $16.49 $1.2 Million - $1.83 Million	111,169 Added 76.19%	257,087 $4.05 Million
Q4 2023 Feb 09, 2024	BUY	$9.84 - $20.13 $597,415 - $1.22 Million	60,713 Added 71.26%	145,918 $2.21 Million
Q3 2023 Nov 09, 2023	SELL	$19.63 - $28.29 $3,965 - $5,714	-202 Reduced 0.24%	85,205 $1.71 Million
Q2 2023 Aug 10, 2023	SELL	$17.41 - $30.05 $1.8 Million - $3.1 Million	-103,312 Reduced 54.74%	85,407 $2.41 Million
Q1 2023 May 11, 2023	BUY	$16.14 - $24.94 $1.4 Million - $2.16 Million	86,785 Added 85.14%	188,719 $3.25 Million
Q4 2022 Feb 09, 2023	SELL	$18.07 - $25.6 $1.21 Million - $1.71 Million	-66,881 Reduced 39.62%	101,934 $2.05 Million
Q3 2022 Nov 10, 2022	BUY	$20.23 - $31.73 $768,031 - $1.2 Million	37,965 Added 29.01%	168,815 $3.66 Million
Q2 2022 Aug 10, 2022	BUY	$17.91 - $52.25 $1.78 Million - $5.19 Million	99,406 Added 316.14%	130,850 $3.68 Million
Q1 2022 May 12, 2022	SELL	$41.58 - $80.89 $1.26 Million - $2.44 Million	-30,220 Reduced 49.01%	31,444 $1.45 Million
Q4 2021 Feb 10, 2022	BUY	$66.92 - $84.79 $1.86 Million - $2.36 Million	27,830 Added 82.25%	61,664 $5.18 Million
Q3 2021 Nov 10, 2021	BUY	$46.83 - $73.5 $1.58 Million - $2.49 Million	33,834 New	33,834 $2.26 Million

Others Institutions Holding ZNTL

# of Institutions

142

Shares Held

67.9M

Call Options Held

48.5K

Put Options Held

89.6K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $171M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account